Metastatic sites as predictors in advanced NSCLC treated with PD-1 inhibitors: a systematic review and meta-analysis

• Auteurs principaux: Yangyun Huang (Auteur), Lihuan Zhu (Auteur), Tianxing Guo (Auteur), Wenshu Chen (Auteur), Zhenlong Zhang (Auteur), Wujin Li (Auteur), Xiaojie Pan (Auteur)
• Format: Livre
• Publié: Taylor & Francis Group, 2021-05-01T00:00:00Z.
• Sujets: article
• Accès en ligne: Connect to this object online.

Background Programmed cell death protein 1 (PD-1) inhibitors are the first-line treatment for advanced non-small-cell lung cancer (NSCLC) patients. However, their efficacy in metastatic NSCLC patients remains controversial. Aim of the study The aim of our study was to evaluate the prognosis of advan...